Aisling Capital
Highly Engaged Employees
Highly Engaged EmployeesFinance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
888 7th Ave Fl 12, New York City, New Yo...Phone Number
(212) 651-6380Website
www.aislingcapital.comRevenue
$5.6 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
3
1
3
About Aisling Capital
Aisling Capital is a leading investment firm specializing in companies that develop and commercialize innovative healthcare products, services, and technologies. The firm focuses on biopharmaceutical development and offers commercial outsourcing services, targeting areas such as genomically defined cancers, neuroscience compounds, and food allergies. With over $1.8 billion in assets and a team boasting over 150 years of combined healthcare experience, Aisling Capital is dedicated to investing in transformative healthcare solutions. Their portfolio includes notable companies like Loxo, Biohaven, and Aimmune, among others.Explore more
Aisling Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aisling Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Aisling Capital recently announced quarterly report
Check if Aisling Capital has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Aisling Capital is spiking on competitors!
Click to see if Aisling Capital had a recent Job posting/layoffs
Product Launch: Get notified when Aisling Capital launches new products
Funding: Get notified immidiatlly once Aisling Capital has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aisling Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Aisling Capital
Recommended Actions
Reach out to Masked Content who joined Aisling Capital as Masked Content
Find more new buyers
Compare Similar Companies to Aisling Capital
Compare insights from companies similar to Aisling Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aisling Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Aisling Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Aisling Capital.
Aisling Capital Tech Stack
A closer look at the technologies used by Aisling Capital
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Left Company
Executive Move
Aisling Capital News & Media
Dren Bio Raises $65M in Series B Financing
Dren Bio, a Foster City, CA-based clinical-stage biopharmaceutical company, raised $65M in Series B funding. The round was led by Aisling Capital and HBM Healthcare Investments, with participation from Pfizer, ArrowMark Partners, Revelation Partners, SR One, 8VC, Taiho Ventures, BVF Partners, Mission BioCapital and Alexandria Venture Investments, amongst others. In connection with the closing of […] The post Dren Bio Raises $65M in Series B Financing appeared first on FinSMEs.Harris Williams Advises Medical Knowledge Group, LLC on its Sale to Novo Holdings A/S
RICHMOND, Va.--(BUSINESS WIRE)--Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Medical Knowledge Group, LLC (MKG), a portfolio company of Court Square Capital Partners (Court Square) and Aisling Capital (Aisling), on its sale to Novo Holdings A/S (Novo Holdings). MKG is an analytics-driven commercialization platform delivering healthcare provider targeted insights and solutions that maximize the clinical and commercial potential of biopGaruda Therapeutics Raises $72M in Series A Financing
Garuda Therapeutics, a Cambridge, Mass.-based company creating off-the-shelf, durable blood stem cell therapies, raised $72m in Series A financing. The round was led by Aisling Capital, Northpond Ventures and Orbimed, supported by Cormorant Asset Management, Ridgeback Capital Investments, Monashee Investment Management, Sectoral Asset Management, National Resilience, Inc. (Resilience), Mass General Brigham Ventures, among others. Aisling […] The post Garuda Therapeutics Raises $72M in Series A FWugen Raises $172M in Series B Funding
Wugen, a Sant Louis MO- and San Diego CA-based clinical stage biotechnology company, raised $172M in Series B funding. The round was led by Abingworth and Tybourne Capital Management with participation from Fidelity Management & Research Company, Intermediate Capital Group (ICG), Sands Capital, Aisling Capital Management, Alexandria Venture Investments, Velosity Capital, Falcon Edge Capital, RiverVest […] The post Wugen Raises $172M in Series B Funding appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aisling Capital
Sign Up For FreeTo access detailed company insights
Aisling Capital is a leading investment firm specializing in companies that develop and commercialize innovative healthcare products, services, and technologies. The firm focuses on biopharmaceutical development and offers commercial outsourcing services, targeting areas such as genomically defined cancers, neuroscience compounds, and food allergie... Read More
